These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 120)

  • 1. Proceedings: Do anti-psychotic drugs act by dopamine receptor blockade in the nucleus accumbens.
    Crow TJ; Deakin JF; Longden A
    Br J Pharmacol; 1975 Oct; 55(2):295P-296P. PubMed ID: 120
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat.
    Wiesel FA; Sedvall G
    Eur J Pharmacol; 1975 Feb; 30(2):364-7. PubMed ID: 236193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
    Bartholini G
    Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic post synaptic receptors.
    Le Fur G; Burgevin MC; Malgouris C; Uzan A
    Neuropharmacology; 1979 Jul; 18(7):591-4. PubMed ID: 40153
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Action of LSD on supersensitive mesolimbic dopamine receptors.
    Kelly PH
    Br J Pharmacol; 1975 Oct; 55(2):291P. PubMed ID: 1201419
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of structural analogs of butaclamol (a new antipsychotic drug) on striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats.
    Pugsley TA; Merker J; Lippman W
    Can J Physiol Pharmacol; 1976 Aug; 54(4):510-5. PubMed ID: 10057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.
    Robinson SE; Berney S; Mishra R; Sulser F
    Psychopharmacology (Berl); 1979 Aug; 64(2):141-7. PubMed ID: 40288
    [No Abstract]   [Full Text] [Related]  

  • 8. Amantadine and apomorphine: interactions on striatal dopamine receptors.
    Cox B
    Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proceedings: Dopamine receptor and antipsychotic effects (author's transl)].
    Karobath M
    Arzneimittelforschung; 1976; 26(6):1029-30. PubMed ID: 9103
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of carbidine on dopamine turnover in the rat corpus striatum].
    Malikova LA; Arefolov VA
    Farmakol Toksikol; 1980; 43(3):310-3. PubMed ID: 6108865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in mesolimbic homovanillic acid content following discrete modulation of striatal dopamine systems [proceedings].
    Costall B; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):105P-106P. PubMed ID: 454900
    [No Abstract]   [Full Text] [Related]  

  • 12. Adaptive changes of the striatal dopamine system induced by repeated administration of neuroleptics and ergot derivatives.
    Bürki HR
    Adv Biochem Psychopharmacol; 1980; 24():65-8. PubMed ID: 6105806
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S; Watson E; Stanley ME
    J Pharmacol Exp Ther; 1975 Nov; 195(2):265-70. PubMed ID: 1185596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecificity of dopamine receptors involved in the regulation of the kinetic state of tyrosine hydroxylase in striatum and nucleus accumbens.
    Zivkovic B; Guidotti A; Costa E
    J Pharm Pharmacol; 1975 May; 27(5):359-60. PubMed ID: 239138
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties.
    Uzan A; Le Fur G; Mitrani N; Kabouche M; Donadieu AM
    Life Sci; 1978 Jul; 23(3):261-73. PubMed ID: 29181
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in catalepsy and receptor sensitivity following chronic neuroleptic treatment.
    Allikmets LH; Zarkovsky AM; Nurk AM
    Eur J Pharmacol; 1981 Oct; 75(2-3):145-7. PubMed ID: 6119215
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of a new fluorinated tricyclic neuroleptic drug isofloxythepin on the rat striatal dopamine metabolism.
    Valchár M; Metysová J; Dlabac A
    Act Nerv Super (Praha); 1979 Oct; 21(3):130-1. PubMed ID: 42258
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Is metoclopramide a directly acting dopamine receptor antagonist?
    Donaldson IM; Jenner P; Marsden CD; Miller R; Peringer E
    Br J Pharmacol; 1976 Mar; 56(3):373P. PubMed ID: 1260201
    [No Abstract]   [Full Text] [Related]  

  • 20. [The genotypic correlations of the expression of anxiety and dopamine metabolism in the mouse brain].
    Popova NK; Avgustinovich DF; Skrinskaia IuA; Nikulina EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(5):904-10. PubMed ID: 9054142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.